Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results of the Company for the quart...more...
Unaudited standalone and consolidated financial results for the quarter ended 31.12.2025.more...
Bal Pharma Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
The company reported standalone net profit of Rs 1.95 crore for the quarter ended December 31 2025 as compared to Rs 1.16 crore in the same ...more...
Dr.Mukesh Beekamchand ( DIN # 11295580 ) is appointed as Non executive Independent Director of the Company through an ordinary resolution passed by t...more...
Bal Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further the company has informed the Exchange rega...more...
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approv...more...
Compliance certificate as per SEBI (PIT) Regulations for the quarter ended 31.12.2025.more...
As of December 2025 50.86% is owned by Promoters and 49.14% by Public. Among Promoters holding Indian Promoters holds 46.75% and Foreign Promoters ho...more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding postal ballot notice issued on 08.01.2026.more...
Bal Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.12.2025.more...
Bal Pharma Limited has informed the Exchange regarding Notice of Postal Ballotmore...
Postal Ballot notice for appointment of Dr.Mukesh Beekamchand ( DIN # 11295580) as independent Director of the Company.more...
Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.more...
The company reported standalone net profit of Rs 0.78 crore for the quarter ended September 30 2025 as compared to Rs 1.21 crore in the same...more...
BOARD MEETINGS Company Name : Auto Products (I) Date : 03-04-2026